Impact of the COVID-19 pandemic on the distribution and resistance   of multidrug-resistant genes in Minas Gerais, Brazil: challenges and implications

Hoberdan Oliveira Pereira; Marcelo Carneiro; Braulio Roberto Goncalves Marinho Couto; Dhian Renato Almeida Camargo; Carmem Dolores Faria; Amanda Aparecida Felizardo

doi:10.18203/2349-3259.ijct20252195

Authors

Hoberdan Oliveira Pereira Santa Cruz Hospital and Postgraduate Program in Health Promotion, University of Santa Cruz do Sul, Rio Grande do Sul-Brazil
Marcelo Carneiro Santa Cruz Hospital and Postgraduate Program in Health Promotion, University of Santa Cruz do Sul, Rio Grande do Sul-Brazil
Braulio Roberto Goncalves Marinho Couto Biobyte Technology in Epidemiology, Brazil
Dhian Renato Almeida Camargo Ezequiel Dias Foundation, Bacterial and Fungal Diseases Service, Brazil
Carmem Dolores Faria Ezequiel Dias Foundation, Bacterial and Fungal Diseases Service, Brazil
Amanda Aparecida Felizardo Institute of Biological Sciences, Department of Morphology, Federal University of Minas Gerais, Brazil

DOI:

https://doi.org/10.18203/2349-3259.ijct20252195

Keywords:

Anti-microbial stewardship, blaKPC, Infection control, Molecular diagnostics, Multidrug-resistant, Resistance genes, Surveillance

Abstract

Background: Following the COVID-19 pandemic, a significant rise in multidrug-resistant pathogens such as Acinetobacter, Enterobacter, Escherichia, Klebsiella, Providencia, Pseudomonas and Serratia spp. was observed in Minas Gerais, Brazil. Diagnostic disparities and antimicrobial overuse for COVID-19-associated pneumonia likely contributed to resistance gene spread.

Methods: This retrospective, cross-sectional, descriptive study analysed 13,012 Gram-negative bacterial isolates collected from hospitals across Minas Gerais between 2016 and 2022. Samples, including urine, tracheal secretion, blood and surgical wound exudate, were referred to the state public health laboratory (LACEN-MG) based on resistance patterns detected via antibiograms. Genotypic analysis involved PCR screening for resistance genes (blaKPC, blaOXA, blaNDM, blaSPM, blaVIM, blaIMP), categorized by pandemic period (pre-, during and post-COVID-19). The presence of at least one gene indicated multidrug resistance.

Results: Among isolates, 70.8% were fermenting bacilli, mainly Klebsiella spp. (73.8%), 29.2% were non-fermenting, mostly Acinetobacter spp. (62.1%) and Pseudomonas spp. (37.9%). Post-pandemic resistance increased significantly (p<0.05). blaKPC declined in relative frequency (66.3% pre-pandemic to 44.4% post-pandemic) but absolute numbers rose (n=2,906). blaOXA and blaNDM increased to 41.1% and 13.5%, respectively, with blaNDM increasing over sixfold. Mcr-1 appeared exclusively post-pandemic in four isolates. blaSPM, blaVIM and blaIMP remained rare; blaIMP was detected only post-pandemic (0.24%, n=16).

Conclusions: Post-pandemic, resistance gene profiles diversified, with expansion of blaOXA, blaNDM and emergence of mcr-1. Strengthened molecular surveillance, equitable diagnostic access and antimicrobial stewardship are urgently needed in Brazil.

Metrics

Metrics Loading ...

References

World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Geneva: WHO. 2019. Available at: https://iris.who.int/handle. Accessed in 21 February 2025.

Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. DOI: https://doi.org/10.1016/S0140-6736(21)02724-0

Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68. DOI: https://doi.org/10.1093/cid/ciaa530

Hsu J. How COVID-19 is accelerating antimicrobial resistance. BMJ. 2020;369:1983. DOI: https://doi.org/10.1136/bmj.m1983

Bonomo RA. The impact of COVID-19 on antimicrobial resistance in healthcare-associated infections in ICUs: a global perspective. Clin Infect Dis. 2022;75(1):29–31.

Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31(4):87–9. DOI: https://doi.org/10.1128/CMR.00088-17

Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26(7):808–10. DOI: https://doi.org/10.1016/j.cmi.2020.04.024

CDC Global Health. Combating antimicrobial resistance globally during COVID-19. Atlanta: CDC. 2022.

Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D, et al. The impact of COVID-19 on antimicrobial resistance: a systematic review. Lancet Microbe. 2023;4(3):179–91. DOI: https://doi.org/10.1016/S2666-5247(22)00355-X

Al Sulayyim AS, Khan M, Aslam B, Almutairi F, Jabbar A, Aljarba NH, et al. Antimicrobial resistance trends during the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health. 2022;19(21):13746. DOI: https://doi.org/10.3390/ijerph191911931

Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Nota técnica nº 1/2013: medidas de prevenção e controle de infecções por enterobactérias multirresistentes. Brasília: ANVISA; 2013. Available at: http://antigo.anvisa.gov.br/ documents. Accessed on 22 Febbruary 2025.

World Health Organization. Hand hygiene technical reference manual: to be used by health-care workers, trainers and observers of hand hygiene practices. Geneva: WHO. 2009. Available at: https://iris.who.int/bitstream. Accessed on 21 February 2025.

Corrêa JS, Zago LF, Silva-Brandão RR, Oliveira SM, Fracolli LA, Padoveze MC, et al. antimicrobial resistance in Brazil: an integrated research agenda. Rev Esc Enferm USP. 2022;56:10589. DOI: https://doi.org/10.1590/1980-220x-reeusp-2021-0589

Ribeiro EA, Machado GS, Tavares JVA, Rocha MJ, Rabelo PWL. Impacto da pandemia de COVID-19 na ocorrência de resistência bacteriana frente aos antimicrobianos: revisão integrativa. Braz J Dev. 2022;8(7):54080–99. DOI: https://doi.org/10.34117/bjdv8n7-332

World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report Geneva: WHO. 2022. Available from: https://iris.who.int/bitstream. Accessed on 22 February 2025.

World Health Organization. WHO report on antibiotic use in COVID-19 patients. Available at: https://www.who.int. Accessed on 21 January 2025.

Polly M, Almeida BL, Lennon RP, Cortês MF, Costa SF, Guimarães T. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control. 2022;50(2):238–9. DOI: https://doi.org/10.1016/j.ajic.2021.10.014

Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, et al. Assessment of the overall and multidrug-resistant organism bioburden on environmental surfaces in healthcare facilities. Infect Control Hosp Epidemiol. 2016;37(12):1426–32. DOI: https://doi.org/10.1017/ice.2016.198

Soto-Giron MJ, Rodriguez-R LM, Luo C, Elk M, Ryu H, Hoelle J, et al. Biofilms on hospital shower hoses: characterization and implications for nosocomial infections. Appl Environ Microbiol. 2016;82(9):2872–83. DOI: https://doi.org/10.1128/AEM.03529-15

Russo A, Fusco P, Morrone HL, Trecarichi EM, Torti C. New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Rev Anti Infect Ther. 2022;21(1):41–55. DOI: https://doi.org/10.1080/14787210.2023.2151435

Xavier BB, Lammens C, Ruhal R, Malhotra-Kumar S, Butaye P, Goossens H. Identification of a novel plasmid-mediated carbapenem-hydrolyzing β-lactamase (blaNDM-5) in Escherichia coli. J Antimicrob Chemother. 2016;71(3):596–602.